Bryant DW - Search Results

1

Metabolism and mutagenesis of benzidine in Salmonella typhimurium strains TA98 and TA98/1,8-DNP.

De France BF, Carter MH, Josephy PD, Bryant DW, McCalla DR. De France BF, et al. Among authors: bryant dw. Mutat Res. 1985 Nov;144(3):159-63. doi: 10.1016/0165-7992(85)90133-2. Mutat Res. 1985. PMID: 3903486 No abstract available.

2

Metabolism of 1,8-dinitropyrene by Salmonella typhimurium.

Bryant DW, McCalla DR, Lultschik P, Quilliam MA, McCarry BE. Bryant DW, et al. Chem Biol Interact. 1984 May;49(3):351-68. doi: 10.1016/0009-2797(84)90108-x. Chem Biol Interact. 1984. PMID: 6373032

3

Action of nitrofurans on E. coli: mutation and induction and repair of daughter-strand gaps in DNA.

Lu C, McCalla DR, Bryant DW. Lu C, et al. Among authors: bryant dw. Mutat Res. 1979 Jun;67(2):133-44. doi: 10.1016/0165-1218(79)90124-1. Mutat Res. 1979. PMID: 381913

4

Dinitropyrene-resistant Salmonella typhimurium are deficient in an acetyl-CoA acetyltransferase.

Orr JC, Bryant DW, McCalla DR, Quilliam MA. Orr JC, et al. Among authors: bryant dw. Chem Biol Interact. 1985 Aug-Sep;54(3):281-8. doi: 10.1016/s0009-2797(85)80169-1. Chem Biol Interact. 1985. PMID: 2865012

5

Identification of the DNA adduct formed by metabolism of 1,8-dinitropyrene in Salmonella typhimurium.

Andrews PJ, Quilliam MA, McCarry BE, Bryant DW, McCalla DR. Andrews PJ, et al. Among authors: bryant dw. Carcinogenesis. 1986 Jan;7(1):105-10. doi: 10.1093/carcin/7.1.105. Carcinogenesis. 1986. PMID: 3510746

6

Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.

Anderson JG, McCalla DR, Bryant DW, McCarry BE, Bromke AM. Anderson JG, et al. Among authors: bryant dw. Mutagenesis. 1987 Jul;2(4):279-85. doi: 10.1093/mutage/2.4.279. Mutagenesis. 1987. PMID: 3325759

7

Nitrofuran induced mutagenesis and error prone repair in Escherichia coli.

Bryant DW, McCalla DR. Bryant DW, et al. Chem Biol Interact. 1980 Aug;31(2):151-66. doi: 10.1016/0009-2797(80)90002-2. Chem Biol Interact. 1980. PMID: 6993027

8

Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems.

Gupta RS, Bromke A, Bryant DW, Gupta R, Singh B, McCalla DR. Gupta RS, et al. Among authors: bryant dw. Mutagenesis. 1987 May;2(3):179-86. doi: 10.1093/mutage/2.3.179. Mutagenesis. 1987. PMID: 3325741

9

Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses.

Krepinsky A, Bryant DW, Davison L, Young B, Heddle J, McCalla DR, Douglas G, Michalko K. Krepinsky A, et al. Among authors: bryant dw. Environ Mol Mutagen. 1990;15(2):83-92. doi: 10.1002/em.2850150205. Environ Mol Mutagen. 1990. PMID: 2407531

10

Type I nitroreductases of Escherichia coli.

Bryant DW, McCalla DR, Leeksma M, Laneuville P. Bryant DW, et al. Can J Microbiol. 1981 Jan;27(1):81-6. doi: 10.1139/m81-013. Can J Microbiol. 1981. PMID: 7011517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters